Baylor College of Medicine

Clinical features and outcomes in patients with primary immunodeficiency and COVID-19 (H-47440)

Description

Content

This is a study of clinical outcomes in patients with a known PI and documented COVID-19. The purpose of study is to better understand which forms of PI render patients more vulnerable to the effects of COVID-19 and also what general vulnerabilities exist between the two health entities.

Contact

Nicholas L Rider

Phone 1: 717–471–6511

IRB: H-47440

Status:

Active

Created:

Back to topback-to-top